Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study [Phase 2]
A Phase 2 follow-up study reports results on de-intensifying radiation with chemotherapy for low-risk HPV-related oropharyngeal squamous cel…
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients [NA]
Clinical trial update on reduced-intensity therapy for oropharyngeal cancer in non-smoking HPV-16 positive patients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer [Phase 2]
Phase 2 trial evaluating reduced-dose intensity-modulated radiation therapy with or without cisplatin in advanced oropharyngeal squamous cel…
-
CLINICAL_TRIALS trial_result · 2020-05-01Clinical Trial Update: Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck [Phase 3]
Phase 3 clinical trial investigating parenteral nutrition for patients treated for locally advanced inoperable head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging [Phase 2]
Phase 2 imaging trial investigating tumor microenvironment in oropharyngeal squamous cell carcinoma using RGD PET/CT.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 study evaluating chemotherapy with or without bevacizumab for recurrent or metastatic head and neck squamous cell carcinoma; results…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer [Phase 2]
Phase 2 trial evaluating radiation therapy with docetaxel for HPV-related oropharyngeal cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer [Phase 2]
Phase 2 trial of BGJ398 (infigratinib) for FGFR-positive recurrent head and neck cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma
This entry reports completion of a clinical trial evaluating the role of the microbiome as biomarkers in locoregionally advanced oropharynge…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer [NA]
A terminated clinical trial evaluating stereotactic body radiation therapy for high-risk locally advanced head and neck cancers; results wer…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
Long-term study results update how human papillomavirus affects quality of life in patients with oropharyngeal squamous cell carcinoma.
-
CLINICAL_TRIALS withdrawal · 2017-11-13Clinical Trial Update: Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating cetuximab, cisplatin, and BYL719 for HPV-associated oropharyngeal squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) [Phase 1]
Phase 1 trial evaluating induction chemotherapy with afatinib, ribavirin, and weekly carboplatin/paclitaxel for HPV-associated stage IVA/IVB…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer [NA]
A completed clinical trial evaluated whether dexamethasone reduces oral pain and dry mouth after surgery in patients with oropharyngeal canc…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca [Phase 2]
This Phase 2 trial update reports results on de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamou…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
Clinical trial update on using PET/MRI to evaluate oropharyngeal squamous cell carcinoma, a form of head and neck cancer; the current trial …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC [Phase 3]
A Phase 3 trial update comparing cetuximab to cisplatin in HPV-positive oropharyngeal squamous cell carcinoma, focusing on early and late to…
-
CLINICAL_TRIALS other · 2017-05-04Clinical Trial Update: Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) [NA]
Terminated clinical trial update from UNC Lineberger Comprehensive Cancer Center on monitoring oral HPV infection in HPV-positive oropharyng…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating the combination of capecitabine and vorinostat for recurrent/metastatic head and neck squamous cell carcinomas wa…
-
CLINICAL_TRIALS research · 2017-01-05Clinical Trial Update: Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot [Phase 2]
Phase II multicenter trial evaluating sentinel node detection in oropharyngeal squamous cell carcinoma (T1-T2N0) treated with radiotherapy a…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC [Phase 1]
Terminated Phase I trial from Virginia Commonwealth University evaluating IMRT with molecular-image guided adaptive radiation therapy for ad…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery [Phase 2]
Phase 2 clinical trial evaluating whether soy isoflavones can prevent recurrence of head and neck squamous cell carcinomas after surgery; re…
-
CLINICAL_TRIALS research · 2016-09-22Clinical Trial Update: A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck [Phase 1]
A Phase 1 dose-escalation study of GC4419 in combination with chemoradiation for head and neck squamous cell carcinomas, including cancers o…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable [NA]
A completed randomized, open-label study assessing lymph node management strategies for early-stage squamous cell carcinoma of the oral cavi…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Ganetespib Window of Opportunity Study in Head and Neck Cancers [Phase 1]
A Phase 1 window-of-opportunity study of ganetespib in head and neck squamous cell carcinomas has been terminated, involving hypopharyngeal,…